Clinical trials
Prostatic Hyperplasia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Unknown status | 7 |
| Terminated | 5 |
| Recruiting | 4 |
| Active, not recruiting | 4 |
| Not yet recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre hospitalier de l'Université de Montréal (CHUM) | 4 |
| Thunder Bay Regional Health Research Institute | 4 |
| Eli Lilly and Company | 3 |
| University of Manitoba | 3 |
| AEterna Zentaris | 2 |
| Allergan | 2 |
| CMX Research | 2 |
| GlaxoSmithKline | 2 |
| Medi-Tate Ltd. | 2 |
| QLT Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 53 |
| Lower Urinary Tract Symptoms | 9 |
| Prostatic Neoplasms | 4 |
| Urinary Bladder, Overactive | 3 |
| Urinary Retention | 2 |
| Color Vision Defects | 1 |
| Erectile Dysfunction | 1 |
| Hyperplasia | 1 |
| Prostatic Diseases | 1 |
| Urinary Incontinence | 1 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.